Source: Annual Congress 2001 - Mechanisms of airway inflammation in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Antczak, S. A. Kharitonov, P. Montuschi, P. Gorski, P. J. Barnes (Lodz, Poland; London, United Kingdom). Increased exhaled 8-isoprostane in aspirin-sensitive asthma. Eur Respir J 2001; 16: Suppl. 31, 1688

Member's Comments

No comment yet.

Related content which might interest you: Increased exhaled 8-isoprostane in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 Leukotrienes and 8-isoprostane in exhaled breath condensate of children with asymptomatic steroid-naive asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Exhaled 8-isoprostane as a marker of airway inflammation in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Cysteinyl leukotrienes in exhaled breath condensate are reduced after mite avoidance in allergic asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Allergic rhinitis is associated with elevated adenosine level in exhaled breath condensate in nonasthmatic patients Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003 Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Levels of 8-isoprostane and LTB4 in exhaled breath condensate (EBC) in seasonal allergic rhinitis. Effect of therapy and allergen exposure Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004 Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma Source: Eur Respir J 2002; 20: 1393-1398 Year: 2002 Exhaled breath condensate: 8-isoprostane and eicosanoids Source: Eur Respir Monogr 2010; 49: 196-206 Year: 2010 Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Discordance between sputum eosinophil counts and exhaled nitric oxide levels in asthma Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Increased exhaled nitric oxide in nonatopic asthma Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003 Exhaled nitric oxide and bronchial hyperresponsiveness in steroid-naive patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 369s Year: 2006 Exhaled breath condensate eicosanoids as markers of asthma severity Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Exhaled breath condensate nitrate/nitrite in asthma, COPD and healthy controls Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006